Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-07-31, with 34 holding rows worth $622,123,000.

Accession
0001567619-19-015514
Filed
2019-07-31
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 34 entries on the cover page, a total value of $622,123,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $622,123,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Bristol-Myers Squibb Company110122108COM1,351,722$61,301,000thousands by filing date
Abbott Laboratories002824100COM687,260$57,799,000thousands by filing date
Boston Scientific Corporation101137107COM1,108,336$47,636,000thousands by filing date
BAXTER INTL INC071813109COM462,305$37,863,000thousands by filing date
Gilead Sciences,Inc.375558103COM445,056$30,068,000thousands by filing date
NUVASIVE INC670704105COM499,354$29,232,000thousands by filing date
REVVITY INC714046109COM300,198$28,921,000thousands by filing date
BIOGEN INC COM09062X103Stock115,126$26,925,000thousands by filing date
INCYTE CORP COM45337C102Stock313,893$26,668,000thousands by filing date
BIO RAD LABS INC090572207CL A85,026$26,578,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock289,065$21,584,000thousands by filing date
Elevance Health, Inc.036752103COM73,107$20,632,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock57,635$18,040,000thousands by filing date
HUMANA INC COM444859102Stock66,900$17,749,000thousands by filing date
QIAGEN NVN72482123SHS NEW423,501$17,173,000thousands by filing date
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS874060205ADR796,299$14,094,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock277,844$13,231,000thousands by filing date
BRUKER CORP116794108COM223,004$11,139,000thousands by filing date
PATTERSON COS INC703395103COM469,255$10,746,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM229,498$10,327,000thousands by filing date
MYLAN NVN59465109SHS EURO504,592$9,607,000thousands by filing date
CVS Health Corporation126650100COM175,743$9,576,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM197,299$9,293,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock131,514$8,452,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock64,742$8,442,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock328,662$6,790,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM431,425$6,415,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock185,042$6,254,000thousands by filing date
MCKESSON CORP COM58155Q103Stock44,175$5,937,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock203,925$5,532,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock71,900$5,217,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM102,913$5,133,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM79,653$5,058,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM251,698$2,711,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-19-015514this filing2019-07-31acceptance time not in the bulk data set